Please use this identifier to cite or link to this item:
|Title:||Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer||Authors:||Tan, B.-J.
Peroral drug delivery
|Issue Date:||2012||Citation:||Tan, B.-J., Liu, Y., Chang, K.-L., Lim, B.K.W., Chiu, G.N.C. (2012). Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. International Journal of Nanomedicine 7 : 651-661. ScholarBank@NUS Repository. https://doi.org/10.2147/IJN.S26538||Abstract:||Background: Realizing the therapeutic benefits of quercetin is mostly hampered by its low water solubility and poor absorption. In light of the advantages of nanovehicles in the delivery of flavanoids, we aimed to deliver quercetin perorally with nanomicelles made from the diblock copolymer, polyethylene glycol (PEG)-derivatized phosphatidylethanolamine (PE). Methods: Quercetin-loaded nanomicelles were prepared by using the film casting method, and were evaluated in terms of drug incorporation efficiency, micelle size, interaction with Caco-2 cells, and anticancer activity in the A549 lung cancer cell line and murine xenograft model. Results: The incorporation efficiency into the nanomicelles was ≥88.9% when the content of quercetin was up to 4% w/w, with sizes of 15.4-18.5 nm and polydispersity indices of||Source Title:||International Journal of Nanomedicine||URI:||http://scholarbank.nus.edu.sg/handle/10635/106201||ISSN:||11769114||DOI:||10.2147/IJN.S26538|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Aug 4, 2020
WEB OF SCIENCETM
checked on Jul 27, 2020
checked on Aug 1, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.